These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30858145)

  • 1. DCE-MRI and Quantitative Histology Reveal Enhanced Vessel Maturation but Impaired Perfusion and Increased Hypoxia in Bevacizumab-Treated Cervical Carcinoma.
    Hauge A; Gaustad JV; Huang R; Simonsen TG; Wegner CS; Andersen LMK; Rofstad EK
    Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):666-676. PubMed ID: 30858145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DCE-MRI of Sunitinib-Induced Changes in Tumor Microvasculature and Hypoxia: A Study of Pancreatic Ductal Adenocarcinoma Xenografts.
    Wegner CS; Hauge A; Simonsen TG; Gaustad JV; Andersen LMK; Rofstad EK
    Neoplasia; 2018 Jul; 20(7):734-744. PubMed ID: 29886124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DCE-MRI of patient-derived xenograft models of uterine cervix carcinoma: associations with parameters of the tumor microenvironment.
    Hauge A; Wegner CS; Gaustad JV; Simonsen TG; Andersen LMK; Rofstad EK
    J Transl Med; 2017 Nov; 15(1):225. PubMed ID: 29100521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DCE-MRI of the hypoxic fraction, radioresponsiveness, and metastatic propensity of cervical carcinoma xenografts.
    Ellingsen C; Hompland T; Galappathi K; Mathiesen B; Rofstad EK
    Radiother Oncol; 2014 Feb; 110(2):335-41. PubMed ID: 24231244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic contrast-enhanced MRI of the microenvironment of pancreatic adenocarcinoma xenografts.
    Wegner CS; Hauge A; Gaustad JV; Andersen LMK; Simonsen TG; Galappathi K; Rofstad EK
    Acta Oncol; 2017 Dec; 56(12):1754-1762. PubMed ID: 28661213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early effects of low dose bevacizumab treatment assessed by magnetic resonance imaging.
    Gaustad JV; Simonsen TG; Smistad R; Wegner CS; Andersen LM; Rofstad EK
    BMC Cancer; 2015 Nov; 15():900. PubMed ID: 26573613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of tumor microvascular response to brivanib by dynamic contrast-enhanced 7-T MRI in an orthotopic xenograft model of hepatocellular carcinoma.
    Song KD; Choi D; Lee JH; Im GH; Yang J; Kim JH; Lee WJ
    AJR Am J Roentgenol; 2014 Jun; 202(6):W559-66. PubMed ID: 24848850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic contrast-enhanced magnetic resonance imaging of the metastatic potential of melanoma xenografts.
    Ovrebø KM; Ellingsen C; Galappathi K; Rofstad EK
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e121-7. PubMed ID: 22381901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of hypoxia in human cervical carcinoma xenografts by dynamic contrast-enhanced magnetic resonance imaging.
    Ellingsen C; Egeland TA; Gulliksrud K; Gaustad JV; Mathiesen B; Rofstad EK
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):838-45. PubMed ID: 19215820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. R2* Relaxation Affects Pharmacokinetic Analysis of Dynamic Contrast-Enhanced MRI in Cancer and Underestimates Treatment Response at 7 T.
    Kim J; Moestue SA; Bathen TF; Kim E
    Tomography; 2019 Sep; 5(3):308-319. PubMed ID: 31572792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. pO₂ fluctuation pattern and cycling hypoxia in human cervical carcinoma and melanoma xenografts.
    Ellingsen C; Ovrebø KM; Galappathi K; Mathiesen B; Rofstad EK
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1317-23. PubMed ID: 22270159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic contrast-enhanced magnetic resonance imaging for monitoring the anti-angiogenesis efficacy in a C6 glioma rat model.
    Hou W; Li X; Pan H; Xu M; Bi S; Shen Y; Yu Y
    Acta Radiol; 2020 Jul; 61(7):973-982. PubMed ID: 31739674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive monitoring of radiotherapy-induced microvascular changes using dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) in a colorectal tumor model.
    Ceelen W; Smeets P; Backes W; Van Damme N; Boterberg T; Demetter P; Bouckenooghe I; De Visschere M; Peeters M; Pattyn P
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1188-96. PubMed ID: 16457965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI Distinguishes Tumor Hypoxia Levels of Different Prognostic and Biological Significance in Cervical Cancer.
    Hillestad T; Hompland T; Fjeldbo CS; Skingen VE; Salberg UB; Aarnes EK; Nilsen A; Lund KV; Evensen TS; Kristensen GB; Stokke T; Lyng H
    Cancer Res; 2020 Sep; 80(18):3993-4003. PubMed ID: 32606004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring imatinib decreasing pericyte coverage and HIF-1α level in a colorectal cancer model by an ultrahigh-field multiparametric MRI approach.
    Hu X; Ye K; Bo S; Xiao Z; Ma M; Pan J; Zhong X; Zhang D; Mo X; Yu X; Chen M; Luo L; Shi C
    J Transl Med; 2024 Jul; 22(1):712. PubMed ID: 39085929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of dynamic contrast-enhanced MRI derived microvascular permeability in recurrent glioblastoma treated with bevacizumab.
    Kickingereder P; Wiestler B; Graf M; Heiland S; Schlemmer HP; Wick W; Wick A; Bendszus M; Radbruch A
    J Neurooncol; 2015 Jan; 121(2):373-80. PubMed ID: 25359396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring hypoxia and vasculature during bevacizumab treatment in a murine colorectal cancer model.
    Heijmen L; Ter Voert EG; Punt CJ; Heerschap A; Oyen WJ; Bussink J; Sweep CG; Laverman P; Span PN; de Geus-Oei LF; Boerman OC; van Laarhoven HW
    Contrast Media Mol Imaging; 2014; 9(3):237-45. PubMed ID: 24700751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlations of 3T DCE-MRI quantitative parameters with microvessel density in a human-colorectal-cancer xenograft mouse model.
    Ahn SJ; An CS; Koom WS; Song HT; Suh JS
    Korean J Radiol; 2011; 12(6):722-30. PubMed ID: 22043155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring tumour microenvironment changes during anti-angiogenesis therapy using functional MRI.
    Liang J; Cheng Q; Huang J; Ma M; Zhang D; Lei X; Xiao Z; Zhang D; Shi C; Luo L
    Angiogenesis; 2019 Aug; 22(3):457-470. PubMed ID: 31147887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of dynamic MRI in monitoring the microenvironmental changes of anti-vascular therapy in a xenograft model].
    Liang JY; Xiao ZY; Zhang D; Ma MJ; Huang JX; Shi CZ; Luo LP
    Zhonghua Yi Xue Za Zhi; 2020 Jan; 100(1):51-56. PubMed ID: 31914559
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.